KRT7 and cancer: Either elevation of cleaved-caspase3 and cleaved-PARP levels by KRT7-AS overexpression (Fig. 5G–J) or reduction of cleaved-caspase3 and cleaved-PARP levels in cancer cells by silencing of KRT7-AS (Fig. 5K, L) was in a time-dependent manner.